Viscofan Valuation Multiples

Viscofan is valued at $2.7B as of October 2026, a 2.1x revenue multiple. In the last 12 months, Viscofan revenue was $1.5B and Viscofan EBITDA was $334M.

Viscofan Overview

About Viscofan

Viscofan SA is a casing market and offers growth propositions in the food and health sectors outside the traditional business. It engaged in the manufacture, distribution, and marketing of all types of casings and films for food use. Its products include Cellulose, Collagen, Fibrous, Functional solutions, Plastics, Viscofan Veggie, eFAN, and Edileaf. It also manufactures casings, films, and bags obtained through the treatment of plastic polymers. It has a geographic presence in EMEA, APAC, North America, and South America with key revenue generation from EMEA.


Founded

1975

HQ

Spain

Employees

6.0K

Financials (LTM)

Revenue: $1.5B
EBITDA: $334M

EV

$3.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Viscofan Financials

Viscofan reported last 12-month revenue of $1.5B and EBITDA of $334M.

In the same LTM period, Viscofan generated $1B in gross profit, $334M in EBITDA, and $178M in net income.

Revenue (LTM)


Viscofan P&L

In the most recent fiscal year, Viscofan reported revenue of $1.4B and EBITDA of $303M.

Viscofan is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 22%, and net margin of 13%.

See analyst estimates for Viscofan
LTMLast FY202320242025202620272028
Revenue$1.5B$1.4B$1.4B$1.4B$1.4B
Gross Profit$1B$947M$931M$941M$947M
Gross Margin67%67%66%68%67%
EBITDA$334M$303M$300M$348M$303M
EBITDA Margin23%22%21%25%22%
EBIT Margin16%16%15%17%16%
Net Profit$178M$180M$163M$182M$180M
Net Margin12%13%11%13%13%
Net Debt-$236M---

Financial data powered by Morningstar, Inc.

Viscofan Stock Performance

Viscofan has current market cap of $2.7B, and enterprise value of $3.1B.

Market Cap Evolution


Viscofan's stock price is $60.66.

Viscofan share price increased by 0.3% in the last 30 days, and decreased by 3.1% in the last year.

Viscofan has an EPS (earnings per share) of $3.97.

See more trading valuation data for Viscofan
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3.1B$2.7B0.0%0.3%-8.4%-3.1%$3.97

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Viscofan Valuation Multiples

Viscofan trades at 2.1x EV/Revenue multiple, and 9.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Viscofan

EV / Revenue (LTM)


Viscofan Financial Valuation Multiples

As of October 20, 2026, Viscofan has market cap of $2.7B and EV of $3.1B.

Viscofan has a P/E ratio of 15.4x.

LTMLast FY202320242025202620272028
EV/Revenue2.1x2.2x2.2x2.2x2.2x
EV/EBITDA9.2x10.1x10.2x8.8x10.1x
EV/EBIT13.0x13.4x14.3x13.1x13.4x
EV/Gross Profit3.1x3.2x3.3x3.3x3.2x
P/E15.4x15.3x16.8x15.1x15.3x
EV/FCF21.5x25.8x38.7x16.5x25.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Viscofan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Viscofan Margins & Growth Rates

Viscofan grew revenue by 6% and EBITDA by 10% in the last fiscal year.

In the most recent fiscal year, Viscofan reported gross margin of 67%, EBITDA margin of 22%, and net margin of 13%.

See estimated margins and future growth rates for Viscofan

Viscofan Margins

Last FY202420252026202720282029
Gross Margin67%68%67%67%
EBITDA Margin22%25%22%22%
EBIT Margin16%17%16%16%
Net Margin13%13%13%12%
FCF Margin8%13%8%10%

Viscofan Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%(2%)1%6%
Gross Profit Growth6%1%1%6%
EBITDA Growth10%16%(13%)10%
EBIT Growth2%9%(2%)2%
Net Profit Growth(2%)11%(1%)(2%)
FCF Growth24%134%(36%)24%

Data powered by FactSet, Inc. and Morningstar, Inc.

Viscofan Operational KPIs

Viscofan's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Viscofan's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Viscofan's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Viscofan
LTMLast FY202320242025202620272028
Rule of 4028%28%---
Bessemer Rule of X35%36%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
G&A Expenses to Revenue-6%6%6%6%
R&D Expenses to Revenue-0%0%0%0%
Opex to Revenue-51%51%51%51%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Viscofan Competitors

Viscofan competitors include Ardagh Metal Packaging, Verallia, Graphic Packaging, Daicel, Huhtamaki, LINTEC, SKC, Ableprint, Vidrala and Winpak.

Most Viscofan public comparables operate across Packaging & Containers.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Ardagh Metal Packaging$5.5B$653M1.3x1.2x10.7x9.0x
Verallia$3.7B$703M1.3x1.2x6.7x6.0x
Graphic Packaging$8.6B$1.3B0.9x0.9x6.0x7.2x
Daicel$3.7B$455M1.1x1.0x8.7x7.1x
Huhtamaki$4.4B$599M1.1x1.0x7.9x6.9x
LINTEC$2B$262M0.9x0.9x7.2x6.4x
SKC$1.4B($430M)4.3x3.5x(13.8x)77.7x
Ableprint$71M$35M26.4x17.5x53.5x31.1x

This data is available for Pro users. Sign up to see all Viscofan competitors and their valuation data.

Start Free Trial

Acquisitions by Viscofan

Viscofan has acquired 1 company to date.

Last acquisition by Viscofan was on February 27th 2025. Viscofan acquired Pet Mania Comércio Internacional for $35M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Viscofan

Pet Mania Comércio Internacional
Description
Pet Mania Comércio Internacional is a São Paulo-based producer and exporter of animal-derived pet treats. Specializing in beef, chicken, and fish-based chews, the company supplies bulk natural snacks to distributors in Latin America and Europe. Its product range includes dehydrated ears, tendons, and pâtés processed in HACCP-certified facilities. Operating since 2010, Pet Mania sources from Brazilian farms and exports to over 15 countries, emphasizing preservative-free formulations for dogs and cats.
HQ CountryBrazil
HQ City
São Paulo
Deal Date27 Feb 2025
Valuation$35M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Viscofan acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Viscofan

Viscofan has invested in 5 companies to date.

Latest investment by Viscofan was on July 15th 2026. Viscofan invested in BZERO in their $2M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Viscofan

BZERO
MOA
Inmedical Therapeutics
Cocoon Bioscience
Description
BZERO is a Valencia advanced-materials company founded in 2021. It develops home-compostable thin film intended to replace polyethylene in packaging such as produce bags, labels and nets. The material is engineered to run on existing industrial conversion lines while matching conventional plastic on strength, thinness and cost. Packaging producers and consumer-goods suppliers are the company's business customers. Revenue is expected from commercial material sales and industrial supply relationships rather than consumer subscriptions. BZERO moved from pilot production toward commercialization as European packaging rules increased demand for compostable alternatives. Ship2B Ventures led a EUR 1.5 million seed financing in 2026 after recording the company as a portfolio holding from 2022.
MOA Foodtech is a Pamplona biotechnology company founded in 2020. It uses fermentation and artificial intelligence to transform side streams and by-products from the food industry into nutritious ingredients. The process combines selected microorganisms with feedstocks that would otherwise have limited value, creating protein-rich biomass for food formulations. Food manufacturers are the company’s principal customers, and potential applications include alternative protein, nutrition and functional ingredients. MOA develops strains, fermentation recipes and production processes and works with industrial partners to validate inputs and end products. The company is based in Spain and is unrelated to an Israel-based business incorrectly described in the prior database text. Its revenue model is expected to combine ingredient sales, production partnerships and licensing of fermentation technology.
Inmedical Therapeutics is a UK-based medtech company developing Covergel, a hydrogel barrier for therapeutic endoscopies. The product minimizes perforation risks during procedures like ESD and POEM by sealing mucosal defects. Currently in preclinical trials, Covergel biodegrades within days and integrates with standard endoscopes. Inmedical targets gastroenterology markets in Europe and the United States.
Cocoon Bioscience is a Barcelona-headquartered biotechnology company that produces recombinant growth factors and specialized enzymes critical for cellular agriculture and precision fermentation processes. The firm supplies high-performance FGF2 variants to cultivated meat producers such as Upside Foods and Aleph Farms, enabling efficient cell proliferation and differentiation in serum-free media. Cocoon Bioscience also develops custom media supplements for alternative protein development and regenerative medicine applications in healthcare. Operating GMP-compliant facilities in Spain, the company supports over 50 biotech clients across Europe, North America, and Asia, focusing on scalable biomanufacturing solutions for nutrition sectors.
HQ CountrySpainSpainSpainSpain
HQ City
Valencia
Pamplona
Vitoria-Gasteiz
Madrid
Deal Date15 Jul 202625 Jun 202417 Jan 20243 Nov 2023
RoundSeedSeries ASeedSeed
Raised$2M$3M$900K$2M
InvestorsTorribas; CTL Investments; Viscofan; Ship2B Ventures; Impact ShakersSODENA; Viscofan; ICOS Capital Management; Banco Sabadell; Clave MayorGestion De Capital Riesgo Del Pais Vasco; ViscofanMondragon Health; Sangha Capital; Viscofan; Bexen Medical; Spri; North South Ventures; Columbus Venture Partners; Cleon Capital
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Viscofan investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Viscofan

When was Viscofan founded?Viscofan was founded in 1975.
Where is Viscofan headquartered?Viscofan is headquartered in Spain.
How many employees does Viscofan have?As of today, Viscofan has over 6K employees.
Who is the CEO of Viscofan?Viscofan's CEO is Jose Antonio Canales Garcia.
Is Viscofan publicly listed?Yes, Viscofan is a public company listed on Bolsa de Madrid.
What is the stock symbol of Viscofan?Viscofan trades under VIS ticker.
When did Viscofan go public?Viscofan went public in 1990.
Who are competitors of Viscofan?Viscofan main competitors include Ardagh Metal Packaging, Verallia, Graphic Packaging, Daicel, Huhtamaki, LINTEC, SKC, Ableprint, Vidrala, Winpak.
What is the current market cap of Viscofan?Viscofan's current market cap is $2.7B.
What is the current revenue of Viscofan?Viscofan's last 12 months revenue is $1.5B.
What is the current revenue growth of Viscofan?Viscofan revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Viscofan?Current revenue multiple of Viscofan is 2.1x.
What is the current EBITDA of Viscofan?Viscofan's last 12 months EBITDA is $334M.
What is Viscofan's EBITDA margin?Viscofan's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Viscofan?Current EBITDA multiple of Viscofan is 9.2x.
What is the current FCF of Viscofan?Viscofan's last 12 months FCF is $143M.
What is Viscofan's FCF margin?Viscofan's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Viscofan?Current FCF multiple of Viscofan is 21.5x.
How many companies Viscofan has acquired to date?As of October 2026, Viscofan has acquired 1 company.
What was the largest acquisition by Viscofan?$35M acquisition of Pet Mania Comércio Internacional on 27th February 2025 was the largest M&A Viscofan has done to date.
What companies Viscofan acquired?Viscofan acquired Pet Mania Comércio Internacional.
In how many companies Viscofan has invested to date?As of October 2026, Viscofan has invested in 5 companies.
What was the last Viscofan investment?On 15th July 2026 Viscofan invested in BZERO, participating in a $2M Seed round, alongside Torribas, CTL Investments, Ship2B Ventures, and Impact Shakers.
In what companies Viscofan invested in?Viscofan invested in Cocoon Bioscience, MOA, BZERO, Inmedical Therapeutics, and InsektLabel Biotech.

See public comps similar to Viscofan

Lists including Viscofan

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial